The Ninth Circuit on Wednesday upheld a lower court's dismissal of an American Diabetes Association lawsuit over diabetes care in the U.S. Army's Child, Youth and School Services programs, finding it is moot because the policy was updated and lacks standing because the organization did not show any injury.
An electron microscopist told a California jury Wednesday that his laboratory found asbestos in a bottle of Johnson & Johnson baby powder owned by a woman who is alleging the company’s talc products gave her mesothelioma.
The Eleventh Circuit has ruled that the federal government has the authority to challenge Florida's institutionalization of disabled children under Title II of the Americans with Disabilities Act, finding that Congress granted the power even though the act's language may be somewhat ambiguous.
A Tennessee health care company lied about its ability to keep an Illinois hospital open because it would rather cash in on $64 million in liquidated assets than honor a deal to sell it for $20 million, a hospital operator has claimed.
The Federal Communications Commission announced Wednesday that it has launched an automated system that links Medicaid and the agency's Lifeline verification program in an attempt to cut down on waste.
An Illinois appellate court on Tuesday upheld a jury's decision to award zero damages to a woman who was injected with the wrong allergy medication despite also finding negligence, saying the evidence arguably showed damages were too minimal to warrant compensation.
A unit of Swiss drug maker Novartis AG announced Wednesday that it's halting distribution of its versions of heartburn medication Ranitidine, more commonly known as Zantac, because of contaminants found in the drug.
A New York bankruptcy judge Wednesday approved health care provider TridentUSA's Chapter 11 plan, saying the deal handing the company’s ownership over to a major lender was fair and financially sound.
West Virginia’s attorney general has hit Johnson & Johnson and its subsidiary Ethicon with a suit over their pelvic mesh, the problematic medical device that’s already cost several manufacturers billions in courtroom losses.
Dental products company Envista Holdings Corp. and biotechnology company IGM Biosciences Inc. saw shares spike in their public markets debuts Wednesday after pricing initial public offerings that raised a combined $764 million, tapping the services of four law firms.
An Illinois appellate court has rejected a bid from a group of Mattoon, Illinois, municipal retirees to reinstate the bulk of their lawsuit claiming they were improperly required to pay more for health insurance premiums than current city workers, finding they couldn't sue under the state’s insurance code.
Malaysian conglomerate Hong Leong Group is teaming up with TPG Capital to pay roughly $1.2 billion for a portfolio of hospitals in Southeast Asia that are focused on providing accessible and affordable health care to the region's middle class, the companies said Wednesday.
Drug distributors and pharmacies continued to press their surprise effort to disqualify the judge overseeing the opioid multidistrict litigation, saying his recent approval of a novel negotiation class merits their last-minute play.
Nine Senate Democrats, including five running for president, have urged the Federal Trade Commission to look closely at the potential impacts on consumers from consolidation in the drug industry — namely the planned blockbuster mergers between AbbVie and Allergan and Bristol-Myers Squibb and Celgene.
A slew of major drugmakers and distributors on Monday lost their bids to kill a suit brought by Tucson Medical Center Inc. blaming the pharmaceutical giants for financial harm the nonprofit Arizona hospital says it suffered as a result of the companies' roles in the U.S. opioid crisis.
A D.C. federal judge ruled Tuesday that the Centers for Medicare & Medicaid Services exceeded its authority last year when it cut payments by hundreds of millions of dollars for outpatient hospital care that's not actually delivered on hospital campuses.
Besieged opioid maker Purdue Pharma LP made its first appearance in New York bankruptcy court Tuesday, winning approval to pay almost $2 million to key employees and up to $1.5 million in monthly legal fees, while touting its proposed settlement of opioid litigation as a benefit to America.
A husband and wife who worked at an Ohio pediatric hospital for a decade have been accused of stealing medical research while employed at the hospital and marketing it in China.
Senate Majority Leader Mitch McConnell, R-Ky., wants the U.S. Food and Drug Administration to define when it will target companies making and selling unapproved CBD products long before the agency creates regulations to get those products on the market legally, a trade group for the hemp industry said Tuesday.
The Third Circuit on Tuesday revived three whistleblowers' claims that the University of Pittsburgh Medical Center violated the Stark Act and the False Claims Act, ruling that its neurosurgeons' pay structure allegedly incentivized them to conduct extra procedures that would require more hospital services to be billed to Medicare.
A California federal judge won't let dozens of national advocacy groups, think tanks and health care organizations join a trio of lawsuits challenging the Trump administration's recent policy that penalizes immigrants for using certain public benefits.
Two accused fraudsters have agreed to pay over $800,000 to quickly settle claims they used a fake charity to scam terminally ill patients out of hundreds of thousands of dollars, the U.S. Securities and Exchange Commission told a Texas federal judge.
Merck is using a baseless trade secrets suit that vilifies a former employee to get a leg up in separate patent litigation with Pfizer, the ex-worker and Pfizer told a Pennsylvania federal court Monday.
An Illinois federal judge on Monday certified a collective action brought by employees of a Chicago-area hospital who allege they worked more than 40 hours a week taking calls from patients without being paid overtime.
Weil Gotshal & Manges LLP was upfront with a former Insys Therapeutics Inc. executive when the firm was also called upon to represent his former company in bankruptcy proceedings, a firm partner said Monday in an affidavit, pushing back on the executive's claim that he was in the dark about the potential conflict.
One year ago, our firm signed the American Bar Association's well-being pledge and embraced a commitment to providing on-site behavioral health resources, which has since become a key aspect of our well-being program, say Meg Meserole and Kimberly Merkel at Akin Gump.
Despite insurers' claims to the contrary, a Colorado federal court's recent decision in Olsen v. Owners provides a helpful reminder that claims-adjustment communications and documents often fall well outside the ambit of traditional privilege protections, even when an attorney is involved, say Christopher Sheehan and Jan Larson of Jenner & Block.
Recent actions by the U.S. Food and Drug Administration and lawsuits filed by drug manufacturers indicate that it is more important than ever for outsourcing facilities to comply with FDA policies regarding bulk drug substances allowed for use in compounding, say attorneys at Ropes & Gray.
While the U.S. Supreme Court’s Henry Schein decision strengthens the enforceability of arbitration provisions, the Fifth Circuit’s ruling on remand concerning arbitrability authority, exemplifies a need for careful drafting of arbitration clauses, say Andrew Behrman and Brandt Thomas Roessler at Baker Botts.
After our firm signed the American Bar Association’s well-being pledge one year ago, we launched two key programs that included weekly meditation sessions and monthly on-site chair massages to help people address both the mental and physical aspects of working at a law firm, says Marci Eisenstein at Schiff Hardin.
Although the California Department of Health Care Services' updated guidelines expanding telemedicine reimbursement have some shortcomings, they open new channels of care for many Medicaid beneficiaries and raise intriguing prospects for similar programs across the country, say Harsh Parikh and Jill Gordon of Nixon Peabody.
As jurisdictions around the world adapt and modernize to capture revenue that would otherwise escape taxation under frameworks put in place long before today’s technology existed, digital health companies face rising tax uncertainty, say Kathleen Gregor and Elizabeth Smith of Ropes & Gray.
The Federal Communications Commission's proposed plans to modernize and fund its rural health care programs represent a new approach prioritizing patients' nuanced needs, rather than focusing on the rurality of health care providers, says Danielle Frappier of Davis Wright.
The early and prompt provision of samples from all electronically stored information sources as a part of ESI protocol search methodology is consistent with the Federal Rules of Civil Procedure and may allow for significant cost savings during discovery, says Zachary Caplan at Berger Montague.
Three recent federal tax cases show how the U.S. Supreme Court's June decision in Kisor v. Wilkie, substantially restricting agency deference, is affecting interpretation of the many regulations and guidance issued post-tax reform, say Andrew Roberson and Kevin Spencer at McDermott.
In the absence of a federal rule governing deposition location, federal courts are frequently called on to resolve objections to out-of-state deposition notices. Recent decisions reveal what information is crucial to courts in making the determination, says Kevin O’Brien at Porter Wright.
While Monday’s Eleventh Circuit decision in United States v. AseraCare provides the government the opportunity to continue litigating its claims, False Claims Act defendants will undoubtedly take refuge in the less plaintiff-friendly falsity standard articulated by the court, say Derek Adams at Feldesman Tucker and Erica Blachman Hitchings at the Whistleblower Law Collaborative.
Federal Rule of Civil Procedure 57 and its state counterparts provide a method for expediting claims for declaratory judgment that warrants closer attention than it has historically received from litigants and courts, say attorneys at Gibson Dunn.
The U.S. Food and Drug Administration's recent revisions to its bulk drug lists may significantly hinder pharmacies' and outsourcing facilities' ability to get patients access to critical medications, and some of those facilities may sue the FDA for interfering with the practice of medicine, say Rachael Pontikes and Kelly Kearney of Reed Smith.
As the Centers for Medicare & Medicaid Services phases in its new provider enrollment process, only some providers and suppliers will be immediately affected, but in time all providers will need to monitor their affiliations, which could prove challenging, say Jill Wright and Judith Waltz of Foley & Lardner.